In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Tenaya Therapeutics Inc (NASDAQ: TNYA) closed at $1.18 in the last session, down -6.35% from day before closing price of $1.26. In other words, the price has decreased by -$6.35 from its previous closing price. On the day, 11.22 million shares were traded. TNYA stock price reached its highest trading level at $1.31 during the session, while it also had its lowest trading level at $0.9005.
Ratios:
We take a closer look at TNYA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.00 and its Current Ratio is at 6.00. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.09.
On November 30, 2023, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on June 15, 2022, with a $25 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 18 ’25 when Higa Tomohiro sold 2,962 shares for $1.25 per share. The transaction valued at 3,711 led to the insider holds 95,338 shares of the business.
Tingley Whittemore sold 5,053 shares of TNYA for $6,331 on Aug 18 ’25. The Chief Medical Officer now owns 172,803 shares after completing the transaction at $1.25 per share. On Aug 18 ’25, another insider, Ali Faraz, who serves as the Chief Executive Officer of the company, sold 14,533 shares for $1.25 each. As a result, the insider received 18,210 and left with 302,792 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNYA now has a Market Capitalization of 192311664 and an Enterprise Value of 145892896.
Stock Price History:
The Beta on a monthly basis for TNYA is 3.08, which has changed by -0.59450173 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, TNYA has reached a high of $4.01, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is 62.05%, while the 200-Day Moving Average is calculated to be 6.07%.
Shares Statistics:
According to the various share statistics, TNYA traded on average about 2.83M shares per day over the past 3-months and 5679060 shares per day over the past 10 days. A total of 162.98M shares are outstanding, with a floating share count of 156.97M. Insiders hold about 3.69% of the company’s shares, while institutions hold 17.76% stake in the company. Shares short for TNYA as of 1753920000 were 10608109 with a Short Ratio of 3.75, compared to 1751241600 on 10701366. Therefore, it implies a Short% of Shares Outstanding of 10608109 and a Short% of Float of 17.879998999999998.
Earnings Estimates
The stock of Tenaya Therapeutics Inc (TNYA) is currently being evaluated by 7.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.07 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.58 and -$0.75 for the fiscal current year, implying an average EPS of -$0.68. EPS for the following year is -$0.6, with 6.0 analysts recommending between -$0.51 and -$0.73.
